Michael J Calvo

Registered Lobbyist

Disclosed Prior Position

Rep.Taylor NC11 LegCorp, 4/04-1/05 LA,1/05-8/06 SrLegAsst,8/06-1/07 Rep. McHenry PolAdv,1/07-8/07 Rep.Gingrey GA11 SrLegAsst,8/07-1/09 Sr Pol Adv,1/09-8/10 LD,8/10-3/12 DCofS,3/12-1/15 Rep. Hice LD,1/15-8/16

Lobby Filings

Clients

Firms

Years Active

2016–2025

Total Contributed

$1,300

Contributions

Recipients

Contrib Filings

Top Recipient Legislators

Legislator	Pty	St	Total
Richard Hudson	R	NC	$1,000

Top Committees / PACs

Payee	Count	Total
HUDSON FOR CONGRESS	1	$1,000
WALKER4NC	1	$250
MICHAEL CALVO	1	$50

Lobbying Filings

All 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016

Year	Firm	Client	Income
2025 1st Quarter - Report	GSK (FKA GLAXOSMITHKLINE INC.)	GSK (FKA GLAXOSMITHKLINE INC.)	—
2024 4th Quarter - Report	GSK (FKA GLAXOSMITHKLINE INC.)	GSK (FKA GLAXOSMITHKLINE INC.)	—
2024 3rd Quarter - Report	GSK (FKA GLAXOSMITHKLINE INC.)	GSK (FKA GLAXOSMITHKLINE INC.)	—
2024 2nd Quarter - Report	GSK (FKA GLAXOSMITHKLINE INC.)	GSK (FKA GLAXOSMITHKLINE INC.)	—
2024 1st Quarter - Report	GSK (FKA GLAXOSMITHKLINE INC.)	GSK (FKA GLAXOSMITHKLINE INC.)	—
2023 4th Quarter - Report	GSK (FKA GLAXOSMITHKLINE INC.)	GSK (FKA GLAXOSMITHKLINE INC.)	—
2023 3rd Quarter - Report	GSK (FKA GLAXOSMITHKLINE INC.)	GSK (FKA GLAXOSMITHKLINE INC.)	—
2023 2nd Quarter - Report	GSK (FKA GLAXOSMITHKLINE INC.)	GSK (FKA GLAXOSMITHKLINE INC.)	—
2023 1st Quarter - Report	GSK (FKA GLAXOSMITHKLINE INC.)	GSK (FKA GLAXOSMITHKLINE INC.)	—
2022 4th Quarter - Report	GSK (FKA GLAXOSMITHKLINE INC.)	GSK (FKA GLAXOSMITHKLINE INC.)	—

Page 1 of 4 · 37 filings Next

Political Contributions

All 2024 2020 2018

Recipient / Honoree	Legislator	Payee / Committee	Date	Amount
Buddy Carter for Congress	—	MICHAEL CALVO	May 6, 2024	$50
Richard Hudson	Richard Hudson (R, NC)	HUDSON FOR CONGRESS	Sep 16, 2020	$1,000
Mark Walker for Congress	—	WALKER4NC	Jun 29, 2018	$250

Contribution Filings (LD-203)

Year	Period	Posted	Status
2024	Year End	Jan 6, 2025	None
2024	Mid Year	Jul 8, 2024	Active
2023	Year End	Jan 17, 2024	None
2023	Mid Year	Jul 10, 2023	None
2022	Year End	Jan 4, 2023	None
2022	Mid Year	Jul 12, 2022	None
2021	Year End	Jan 6, 2022	None
2021	Mid Year	Jul 9, 2021	None
2020	Year End	Jan 7, 2021	Active
2020	Mid Year	Jul 1, 2020	None
2019	Year End	Jan 13, 2020	None
2019	Mid Year	Jul 8, 2019	None
2018	Year End	Jan 10, 2019	None
2018	Mid Year	Jul 3, 2018	Active
2017	Year End	Jan 16, 2018	None
2017	Mid Year	Jul 20, 2017	None
2016	Year End	Jan 19, 2017	None